Participants:0–17 years · 18–64 years · 65+ years
Substances:H-GLY-LYS-TYR-GLY-PHE-TYR-THR-HIS-VAL-PHE-ARG-LEU-LYS-LYS-TRP-ILE-GLN-LYS-VAL-ILE-ASP-GLN-PHE-GLY-GLU-OH

Contact Research Centre

Prader-Willi syndrome

Recruiting

Investigational

Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Sickle cell disease

Recruiting

Investigational

Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Etavopivat

Contact Research Centre

Small cell lung cancer limited stage

Recruiting

Investigational

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:TIFCEMALIMAB

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Busulfan

Contact Research Centre

Pleural mesothelioma malignant

Recruiting

Registered drug

Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Colorectal cancer stage II+1

Recruiting

Registered drugNo placebo

Study on Aspirin and Metformin for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

Recruiting

Registered drugNo placebo

Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Metastatic renal cell carcinoma

Recruiting

Registered drugNo placebo

Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Axitinib

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Registered drug

Study on the Effects of Acetylcarnitine Hydrochloride in Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:ACETYLCARNITINE HYDROCHLORIDE

Contact Research Centre

Find therapies in clinical trials near you – page 8

381 trials match your criteria

Breast cancer

Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Adrenogenital syndrome

Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

Epidermolysis bullosa

Study on the Effects of TCP-25 Gel for Wound Healing in Patients with Epidermolysis Bullosa

Prader-Willi syndrome

Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

Sickle cell disease

Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Small cell lung cancer limited stage

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Acute myeloid leukaemia

Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

Pleural mesothelioma malignant

Study on Atezolizumab for Patients with Malignant Pleural Mesothelioma After Surgery

Colorectal cancer stage II+1

Study on Aspirin and Metformin for Patients with Locally Advanced Rectal Cancer

Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

Metastatic renal cell carcinoma

Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Amyotrophic lateral sclerosis

Study on the Effects of Acetylcarnitine Hydrochloride in Patients with Amyotrophic Lateral Sclerosis (ALS)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.